Studying fatigue and blood markers in people with multiple sclerosis
Studies fatigue and blood markers of nerve damage in adults with multiple sclerosis.
Plain-language title generated from the registry record
Registry title: Fatigue in Multiple Sclerosis and Its Relationship to Inflammatory and Neurodegenerative Markers of the Disease
Key facts
- Where
- Martin, SlovakiaSee the site
Where in Slovakia
- University Hospital in Martin, Comenius UniversityMartin, SlovakiaNo longer taking part
Questions to ask the study team
- How often do I need to come in, and for how long each time?
- Are travel costs paid?
- Can I keep my own doctor?
- What happens if I want to stop?
Trial details
- Who runs it
- University Hospital, Martin
- Trial code
- NCT07025122
- Record updated
- 17 June 2025
- Original description
The study is focused on several independent quantifiable biomarkers (sNfL, sGFAP, mitochondrial activity, genetics and fatigue tests) to obtain more detailed information about MS and its progression. Based on the results, investigator will further attempt to predict the course of the disease and manage the therapy more effectively to prevent worsening of the patient's condition.Read full original descriptionShow less
Fatigue in Multiple Sclerosis and Its Relationship to Inflammatory and Neurodegenerative Markers of the Disease
The study is focused on several independent quantifiable biomarkers (sNfL, sGFAP, mitochondrial activity, genetics and fatigue tests) to obtain more detailed information about MS and its progression. Based on the results, investigator will further attempt to predict the course of the disease and manage the therapy more effectively to prevent worsening of the patient's condition.
Inclusion: Clinical diagnosis of multiple sclerosis using McDonald2017 criteria Patients indicated to immunomodulatory treatment.
Exclusion: Multimorbidities.